The sella turcica, part of the sphenoid bone located at the base of the skull, is associated with multiple important neurovascular structures. Hence, a detailed knowledge of its variations is critical to clinicians who interpret imaging or surgeons who operate in this region. Our aim was to better understand the pathology of osteophytosis, often found related to the sella turcica. The study sample (n=1,083, human skulls) was obtained from the skeleton collection housed in the Natural History Museum, Cleveland, OH, USA. All skulls were assessed for osteophytes in the sella turcica region (defined as an overgrowth of 1 mm or more). Morphometrical measurements included skull length, width, and thickness, correlated to seller osteophytes. Cranial shape was related to the presence of osteophytes. Greater prevalence was seen in the brachycephalic skulls, with a significantly higher ratio of presence in older people (79.6%) compared to a younger population (26.4%);greater prevalence was also observed in female skulls with a composite thickness of the frontal, parietal and occipital bones.A multifactorial analysis using a logistic regression model defined a statistically significant model, by explaining 37.0% of the variance in osteophyte presence and correctly classifying 77.2% of the cases. Female skulls were 1.76 times more likely to display osteophytes of the sella turcica. Increasing age and increased skull thickness were associated with an enhanced likelihood of exhibiting osteophytes involving the sella turcica, thereby, the shape of the skull, age, and sex partially explain the variations observed for the presence of sella turcica osteophytes.

Bone wound healing is a highly dynamic and precisely controlled process through which damaged bone undergoes repair and complete regeneration. External factors can alter this process, leading to delayed or failed bone wound healing. The findings of recent studies suggest that the use of selective serotonin reuptake inhibitors (SSRIs) can reduce bone mass, precipitate osteoporotic fractures and increase the rate of dental implant failure. With 10% of Americans prescribed antidepressants, the potential of SSRIs to impair bone healing may adversely affect millions of patients' ability to heal after sustaining trauma. Here, we investigate the effect of the SSRI sertraline on bone healing through pre-treatment with (10 mg·kg sertraline in drinking water, n = 26) or without (control, n = 30) SSRI followed by the creation of a 5-mm calvarial defect. Animals were randomized into three surgical groups: (a) empty/sham, (b) implanted with a DermaMatrix scaffold soak-loaded with sterile PBS or (c) DermaMatrix soak-loaded with 542.5 ng BMP2. SSRI exposure continued until sacrifice in the exposed groups at 4 weeks after surgery. Sertraline exposure resulted in decreased bone healing with significant decreases in trabecular thickness, trabecular number and osteoclast dysfunction while significantly increasing mature collagen fiber formation. These findings indicate that sertraline exposure can impair bone wound healing through disruption of bone repair and regeneration while promoting or defaulting to scar formation within the defect site.
Animals ; Apoptosis ; Bone Morphogenetic Protein 2 ; Cell Culture Techniques ; Cell Proliferation ; Enzyme-Linked Immunosorbent Assay ; Immunohistochemistry ; Male ; Mice ; Mice, Inbred C57BL ; Osteogenesis ; drug effects ; Random Allocation ; Real-Time Polymerase Chain Reaction ; Serotonin Uptake Inhibitors ; adverse effects ; pharmacology ; Sertraline ; adverse effects ; pharmacology ; Skull ; diagnostic imaging ; drug effects ; injuries ; Wound Healing ; drug effects ; X-Ray Microtomography